SK4 inhibition by TRAM‐34, however, raised these values to 100%, 90% and 74% at the time points analysed (Fig. 3F,H), again indicating the functional significance of SK4 for Ca2+ signalling in PyMT transgenic breast tumour cells. Here, KCNN4 is linked to breast neoplasm.